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A high-performance hquid chromatographic assay for total hydroxyproline in
serum and gingival crevicular fiuid has been developed. The Clq component of
the first complement factor was precipitated out of the samples with a 0.02 M
sodium acetate solution. Ahquots of the supernatants were dried, vapor hydroly-
zed with 6 M hydrochloric acid at 105°C for 24 hours and derivatized with
phenylisothiocyanate. The derivatives were chromatographed using a multilinear
solvent gradient with detection at 254 nm. The regression of peak areas on the
concentrations of hydroxyproline was linear with a correlation coefficient of 0,99
within the range of assayed quantities (2.5 to 25 ng). Analytical recovery was
90.5 ±2.54% (X + SD) and the determination level was 2.5 ng (19.1 pmol). The
precision of the assay as determined by the coefficient of variation for five
consecutive runs of six concentrations of hydroxyproline in serum hydrolysate
("within-run" precision) and five series run on different days ("between-run" pre-
cision) was 1.8+1.28% and 4.2 + 2.59% (X + SD), respectively. Hydroxyproline
concentrations in GCF from single sites during developing experimental gingivitis
in the beagle dog showed an irregular pattern of low and high concentrations
ranging from 5.2 to 17.4 ng/fA. Accepted for publication September 1, 1986
Introduction
Infiammation and destruction of gin-
gival connective tissue are early and
continuing events in the periodontal dis-
ease process. Gingival crevicular fiuid
(GCF) is an inflammatory exudate of
the dento-gingival vascular plexus (1,2,
3). Due to the low compliance of the
gingival tissues and the high hydraulic
conductance of the crevicular epi-
thelium, the inflammatory exudate car-
ries most of the breakdown products
resulting from the periodontal disease
process out of the tissues and into the
gingival crevice where they appear in
the GCF (4). One logical bioassay for
periodontal disease activity would be
the detection and quantification of these
products in GCF.
Collagens account for about 60% of
the total proteins in normal healthy gin-
giva (5) and are also major constituents
of the periodontal ligament and alveolar
bone. In the healthy state, a high colla-
gen turnover occurs in both gingiva (6)
and periodontal ligament (7, 8) and is
carried out by fibroblasts via phago-
cytosis and lysosomal degradation (9,
10). Enhanced production of enzymes
capable of degrading collagen is associ-
ated with the onset and progression of
periodontal disease (11-14) resulting in
about a 70% loss of the collagen in
the advancing front of the periodontal
lesion (15).
It is generally accepted that degra-
dation of collagen can be monitored by
the release of hydroxyproline (Hyp)
which makes up about 10% ofthis pro-
tein. Consequently, in active periodon-
tal disease with increased degradation
and a net loss of collagen in the peri-
odontal connective tissue, the GCF
would be expected to have increased
concentrations of Hyp.
Clq (MW 409 600), a subunit of the
first complement factor, contains 4.3%
Hyp by weight (16), Systemic as well as
local factors can alter its concentrafion
in the tissues. It is seen coating bacteria
collected from gingival crevices in pa-
tients with chronic periodonfitis (17).
Consequently, in order to accurately
monitor increased degradation and loss
of gingival collagen by determination of
Hyp in GCF, it is imperative to remove
any Clq from the samples. This can be
done by precipitation of Clq with a 0.02
M sodium acetate buffer (18).
The first reasonably sensitive and re-
producible procedure for determination
of Hyp was described by Neuman &
Logan (19). Because of the complexity
of the biological mixtures in which Hyp
is being determined, countless modifi-
cations or separate procedures have
been developed to increase the sensi-
tivity or to improve the specificity of the
assay. A few attempts have been made
































































'A solvent: Sodium acetate (19 g), water
(1000 ml) and triethylamine (0,5 ml) are
mixed and titrated to pH 6.40 with glacial
acetic acid. Mix 967 ml of this solution with
19.8 ml acetonitrile and 13.2 ml water.
"B Solvent: Acetonitrile:water (6:4 by vol.).
'Curve: As defined by Waters Associates: ^6
(linear), ^5 (convex). The final 11 min of the
gradient bring the system into stand-by mode
after unattended, overnight chromatography.
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Fig. I. Standard addition calibration curve
(y=-1914-h5707x; r==0.99) for authentic
rra«,y-4-hydroxy-L-proline. Each point rep-
resents the mean of five consecutive determi-
nations.
to determine Hyp in GCF, However,
the procedures are not sufficiently
sensitive and therefore require pooled
samples rather than specimens taken
from discrete sites (20), and do not take
into account the effects of Clq (21, 22,
23).
This study presents a high-perform-
ance liquid chromatography assay for
low nanogram quantities of collagen-
derived Hyp in 1 to 2 //I volumes of
GCF and serum.
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Fig. 2. Standard addition calibration curve
(y= 14438-f3835x; (r = 0.99) for serum sup-
plemented with rran,s-4-hydroxy-L-proline
before hydrolysis. Each point represents the
mean of five consecutive determinations.
Material and Methods
Apparatus
The high-performance liquid chromato-
graphy system (Waters Associates, Mil-
ford, MA) consisted of the Model 840
Data and Chromatography Control
Station, two Model 510 solvent pumps,
a Model 441 absorbance detector (fixed
wavelength 254 nm; 10 mm fiow cell)
and a Model 71 OB Automatic Sample
Processor. A Pico-Tag column was kept
at a temperature of 38 ± 0.1 °C by means
of a Temperature Control System and
the eluents were kept under a blanket
of helium with an Eluent Stabilization
System. A Savant Model SVCIOOH
Speed Vac Concentrator (Savant, Far-
mingdale, NY) was used for desiccation
to avoid splashing of the fiuid samples
and a Pico-Tag Work Station (Waters
Assoc.) was used for vapor hydrolysis
of the dried specimens.
Reagents
HPLC Grade acetonitrile, sodium ace-
tate and methanol were from Fisher
Scientific, (Livonia, MI) and glacial ace-
tic acid was from Mallinckrodt (St.
Louis, MO). Triethylamine (TEA),
phenylisothiocyanate (PITC) and con-
stant boiling hydrochloric acid were Se-
quanal Grade from Pierce (Rockford,
IL). Pico-Tag Sample Diluent (0.005 M
dibasic sodium phosphate titrated to pH
7.4 with 1 M phosphoric acid:acetonitri-
le; 19:1 by vol.) was obtained from Wa-
ters Associates. Stock solutions of trans-
4-hydroxy-L-proline and cw-4-hydroxy-
D-proline (Sigma Chemical Co., St.
Louis, MO) were made up to a concen-
tration of 1.25 mg/1, and 2 ml ahquots
blanketed with argon were stored at
-20°C until used. A 0.02 M sodium
acetate buffer (Trihydrate, Grade 1, Sig-
ma Chemical Co.), pH 5.5, was stored
at 4°C until used.
Standard curves
Serum was obtained prior to each exper-
iment by collecting blood from a beagle
dog foreleg vein with serum separators
(Microtainer, Becton Dickinson, Ru-
therford, NJ) that were left at 4°C for
60 min, centrifuged at 12700 x ^ for 10
min and the serum retrieved.
Standard curves were generated for
authentic Hyp (Matrix 1) and authentic
Hyp in serum hydrolysate (Matrix 2a).
Six concentrations of supplemented
Hyp were made up by adding 17.5, 35.0,
52.5, 70.0, 87.5 and 175 ng of trans-4-
hydroxy-L-proline to the samples tubes.
In Matrix 1, the Hyp was pipetted into
6 X 50 mm borosilicate glass culture tu-
bes (Corning Glass Works, Corning,
Table 2. Precision of assay for /ra«,?-4-hydroxy-L-proline expressed as the coefficient of














































































' Concentration of supplemented ?rfl«,s-4-hydroxy-L-proline.
^ Authentic ;ranj-4-hydroxy-L-proline samples that were analyzed in five consecutive runs.
' Serum samples that were supplemented with Z/-flW5-4-hydroxy-L-proline before hydrolysis,
and assayed in five consecutive runs.
•* Serum samples that were supplemented with ?ran5-4-hydroxy-L-proline before hydrolysis,
and assayed on different days.
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NY) and the samples were brought to
dryness. In Matrix 2a, the Hyp was
added to 7 //I serum samples in micro
sedimentation polypropylene tubes
(Sarstedt, St. Louis, MO) and the sam-
ples were brought to dryness. Then 100
fil of 0.02 M sodium acetate were added
to the tubes that were left overnight at
4°C for precipitation of Clq. After cen-
trifugation at 12700 xg for 15 s, 90 //I
of the supernatants were brought to
dryness in 6 x 50 mm glass culture tubes.
Five consecutive series of these samples
were processed and chromatographed
on the same day for determination of
"within-run" precision.
A second series of six concentrations
of authentic Hyp in serum (Matrix 2b)
was made up by adding 25, 50, 75, 100,
125 and 250 ng of trans-4-hydroxy-L-
proline to 10 //I serum in micro sedimen-
tation tubes and the samples were
brought to dryness. Precipitation of
Clq was done in 100 fil of 0.02 M so-
dium acetate, as described above, and
10 //I aliquots of the supernatants were
brought to dryness in 6 x 50 mm glass
6.000
culture tubes. Five series of these sam-
ples were processed and chromatogra-
phed on different days for determi-
nation of "between-run" precision.
Samples
Three beagle dogs were given weekly
prophylaxes and had their teeth brushed
every weekday until clinically healthy
periodontal tissues were established, as
determined by the color and consistency
of the gingivae and the absence of GCF
following gentle mechanical stimulation
of the gingiva. Then dental plaque was
allowed to form by refraining from all
oral hygiene measures. Starting 1 wk
later, samples were collected once per
wk over a 5-wk period of developing
gingivitis. The animals were fed no later
than 24 h before sampling. GCF from
mandibular premolars was collected
with tared 2 /il capillary glass tubes
(Drummond Scientific, Broomall, PA)
after gentle mechanical stimulation of
the gingiva. Again, the tubes were








Fig. 3. Chromatograms showing hydroxyprohne peak in A. Serum (3.2 ng) and B. Gingival
crevicular fluid (4,1 ng). Retention time is 5.29 min. Attenuation: 0.005 absorbance units full
scale.
which the GCF samples were retrieved
by fiushing 60 fA of 0.02 M sodium
acetate through the microcapillary tu-
bes. After precipitation of Clq, as de-
scribed above, 50 pd of the supernatants
were brought to dryness in 6 x 50 mm
glass culture tubes.
Hydrolysis
Up to 12 sample tubes were placed in a
glass reaction vial with a resealable te-
fion closure (Waters Assoc.) and 200 pt\
of HCl were dispensed into the reaction
vial, not the sample tubes. Oxygen was
removed from the reaction vials by three
cycles of alternate evacuation (20 s) and
fiushing with nitrogen (5 s) using the
Pico-Tag Work Station. The reaction vi-
als were sealed under vacuum at the end
of the third cycle. The samples were
hydrolyzed at 105 C for 24 h and then
brought to dryness.
Derivatization
Twenty-five microliters of fresh re-
drying solution (methanol:water:TEA,
2:2:1 by vol.) were added to each sample
which was vortexed and brought to dry-
ness. Then 25 //I of fresh derivatization
solution (methanol:water:TEA:PITC;
7:1:1:1 by vol.) were added to the sam-
ples that were vortexed, centrifuged for
20 s in the Speed Vac Concentrator, left
at room temperature for 20 min and
brought to dryness. Seventy microliters
of Sample Diluent:methanol (4:1 by
vol.) were added to the samples (35 //I
to each of the "between-run" samples)
that were vortexed for 10 s and then
passed through Millex-HV4 filters into
low volume inserts (Waters Assoc).
Chromatographic conditions
Two eluents were used: A) Sodium ace-
tate (19 g), water (1000 ml) and TEA
(0.5 ml) were mixed and titrated to pH
6.40 with glacial acetic acid. Then, 19.8
ml acetonitrile and 13.2 ml water were
added to 967 ml of this solution. B)
Acetonitrile:water (6:4 by vol.). The
fiow program (Table 1) started isocratic
with 1 ml/min of 100% A solvent for 4
min followed by a gradient washing step
for 8.5 min and a 7.5 min re-equili-
bration phase. At 20 min the system was
ready for the injection of 10 //I of the
next sample. The final 11 min of the
flow program brought the system into
a stand-by mode after unattended, over-
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Fig. 4. Variations in total /ra«i'-4-hydroxy-L-proline in gingival crevicular fluid from 12
gingival crevices that were sampled I to 5 wk after initiation of experimental gingivitis.
atography of the first actual sample, the
system was equilibrated by doing at
least three blank runs, Absorbance was
determined (254 nm) at a sampling rate
of 4 points/s. To save hard disk storage
space, only the first 8 min of each chro-
matogram were recorded for sub-
sequent integration of the peak areas.
Analytical variables
Cahbration curves were generated for
quintuphcate samples using the stand-
ard-addition method. Peak areas were
plotted against concentrations of sup-
plemented Hyp (range 2.5 to 25.0 ng)
for regression analysis. The curves for
authentic Hyp and authentic Hyp in
serum hydrolysate were compared by
analysis of covariance. In each matrix,
precision was determined for five sam-
ples of six different concentrations of
supplemented Hyp by calculating the
coefficient of variation (CV). Analytical
recovery was determined by comparing
the peak areas of six hydrolyzed ali-
quots of authentic ?ra«,s'-4-hydroxy-L-




The standard curves showed a linear
correlation between peak areas (ab-
sorbance) and concentration of sup-
plemented frfl/7j'-4-hydroxy-L-proline
(Figs. 1 and 2) with a correlation coef-
ficient of 0.99. The regression equafions
(Matrix 1: y= - 1914-1-5707x, Matrix
2a: y=14438 + 3835x) showed that the
calibration curve for Hyp standards in
serum hydrolysate had a higher value
for the y-intercept, accounted for by the
Hyp content in serum, and a significant-
ly (p< 0.0001) lower slope factor than
the calibration curve for authentic Hyp.
Precision and analytical recovery
The precision of the assay was deter-
mined for all three matrices and, as
shown in Table 2, the coefficient of vari-
ation for the six concentrations of Hyp
ranged from 0.6 to 2.7% (Matrix 1), 0.8
to 4.3% (Matrix 2a) and 1.1 to 8.1%
(Matrix 2b). The coefficient of variation
for the slope factors of the five standard
curves in Matrix 2b was 2.5%. The
analytical recovery of the hydrolyzed
/ra«i-4-hydroxy-L-proline samples was
90.5 ±2.54% (X±SD) as compared
with the non-hydrolyzed samples.
Clinical samples
The retention time for Hyp in the GCF
samples was the same as for Hyp in
Matrix 1, 2a and 2b (5.29 min) with
good resolution of the Hyp peak (Fig.
3). One week after plaque was allowed
to form (Fig. 4), GCF from 12 sites
had a concentration of Hyp that ranged
froni 8.4 to 13.6 ng///l (11.3 ±2.15 ng/
//I; X + SD). Over the following 4-wk
period, each site showed an irregular
pattern of increases and decreases in
Hyp concentration in the GCF that ran-
ged from 5.2 to 17.4 ng/fil (9.0 + 2.60
Discussion
A sensitive and reproducible method for
the determination of Hyp in GCF and
serum has been established. It requires
only \ to 2 fi\ volumes of these speci-
mens and has a determination level of
about 2 ng of Hyp.
The slope factor of the calibration
curve for serum hydrolysates sup-
plemented with ^ram-4-hydroxy-L-pro-
line prior to hydrolysis was found to be
significantly lower than the slope factor
of the caUbration curve for authentic
/ra«5-4-hydroxy-L-proline (p < 0.0001).
This might be explained by the demon-
strated 9.5% loss of authentic trans-4-
hydroxy-L-proline during hydrolysis
which has a greater effect on serum
samples with higher concentrations of
supplemented authentic Hyp and
consequently lowers the value of the
slope factor. The loss is explained by the
epimerization of approximately 10% of
the /ra«,5'-4-hydroxy-L-proIine to cis-4-
hydroxy-D-proline (24) that does not
elute with the trans isomer.
In the five experiments performed on
different days (Matrix 2b) the coef-
ficient of variation for the slope factors
of the standard curves was as low as
2.5% and the coefficient of variation for
determination for the six concentrations
of Hyp was only 4.2 ±2.59% (X±SD).
Therefore, external standards were con-
sidered appropriate and manageable for
the low level analyses of the small vol-
ume clinical samples, assuming that
they would add the least measurement
error to the assay.
There was no need for any sample
clean-up other than precipitafion of
Clq despite the fact that the protein
concentration in GCF can be as high as
93 //g///l (25), However, to main-
tain established chromatographic con-
ditions, 20 ml of methanol was pumped
through the column (fiow rate 0.2 ml/
min; column temperature 38°C) after
every 40-50 clinical samples which con-
sistently eluted substantial amounts of
contaminants that had been retained on
the column.
When changing to a new Pico-Tag
column, a slight modification of the A
solvent was required to achieve the opti-
mal retention time and resolution of the
Hyp peak. This was accomplished by
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an increase or decrease ( ± 2 ml) in the
amount of acetonitrile that was added
to the acetate buffer.
The clinical samples showed vari-
ations in Hyp concentration with differ-
ences between sites and within sites over
time. High and low values appeared in
an irregular pattern during the first 5
wk of experimental gingivitis which sug-
gests that, during this period of collagen
breakdown in the gingival connective
tissue (26), the metabolism of this pro-
tein is an irregular rather than a linearly
continuous event.
Leukocytes capable of releasing sub-
stantial amounts of hydrolytic enzymes
accumulate in the gingival tissues dur-
ing the onset and progression of peri-
odontal disease (15). Collagenase is
found at the advancing front of the peri-
odontal lesion (27) and the collagenoly-
tic activity increases with increasing se-
verity and activity of the disease (28,
29). In addition to extracellular degra-
dation of mature collagen, intracellular
degradation of newly synthesized colla-
gen occurs. The basal level of intracellu-
lar degradation of nascent collagen in
healthy connective tissue is estimated to
be 15±5% and has mmimal effect on
collagen producfion (30). However, en-
hanced intracellular degradation above
the baseline level occurs when underhy-
droxylated, non-helical collagen is syn-
thesized (31) and when the fibroblasts
are exposed to agents such as prosta-
glandin E2 that increase intracellular
levels of cAMP (32). In fact, the concen-
trations of prostaglandin E2 and cAMP
increase in the gingival tissues with in-
creasing severity of the disease (33, 34,
35). In addition, collagen-poor, cell-rich
gingival connective tissue incorporates
more [G-'H]-proline in vitro than does
healthy tissue and a larger portion of
the protein-bound activity is found in
the culture medium (36) suggesting an
increased synthesis of collagen in the
diseased tissue. Since there is no ac-
cumulation of collagen, there is reason
to believe that the reported increase in
synthesis is counterbalanced by an en-
hanced intracellular degradation of na-
scent collagen.
Because of the high collagen turnover
rate in gingiva, zero production of colla-
gen due to enhanced intracellular degra-
dation may contribute to loss of colla-
gen in periodontal disease (6). Conse-
quently, the amount of collagen-derived
Hyp in GCF from this process, as well
as extracellular degradation of mature
collagen, may refiect collagen loss and
disease activity in the periodontal dis-
ease process. Therefore, this sensitive
and reproducible method for determi-
nation of Hyp in complex biological
samples may serve as a useful, non-in-
vasive assay for loss of collagen during
progressive periodontal disease and
may have the potential for assessment
of periodontal disease activity.
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